Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies, Ewing Sarcoma, Vomiting in Infants and/or Children, Osteosarcoma
In brief
This randomized pilot clinical trial studies giving acupuncture in reducing nausea and vomiting in patients undergoing chemotherapy. Pressing and stimulating nerves at an acupuncture point on the inside of the wrist may help control nausea and vomiting during chemotherapy.
Key facts
- Study ID
- NCT01492569
- Run by
- Stanford University
- People needed
- 0
- Starts
- 2012-05-01
- Last updated by the study team
- 2013-06-12
Who can join
Age: 8 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient with a planned admission for at least 24 hours for highly emetogenic or moderately emetogenic chemotherapy at Lucile Packard Children's Hospital or Packard El Camino.
- Planned to undergo at least 2 more cycles of chemotherapy.
- Can include but not limited to: children with high risk ALL, AML, Ewing's Sarcoma, Osteosarcoma
- History of vomiting with prior cycles of chemotherapy (2 episodes of emesis at minimum) despite use of conventional antiemetic medications.
- Age 8-21.
- Parent must be able to understand and willing to sign written informed consent document.
You may not qualify if…
- Prior knowledge of acupuncture or experience with acupuncture or acupressure.
- There will be no restrictions regarding use of other Investigational Agents.
- Comorbid Diseases:
- Diagnosis of any cardiac condition (cardiomyopathy, arrhythmia, pacemaker placement).
- Any diagnosis requiring pediatric intensive care unit admission.
- Patients with brain tumor, brain metastasis (these patients often require radiation and surgery in addition to chemotherapy which may confound the results)
- Concomitant radiation therapy during current chemotherapy cycle.
- Developmental delay patients with allergy to tape or leads will be excluded from the study.
- Pregnant patients will be excluded from the study.
- Cancer survivors will not be excluded from the study as long as they are undergoing chemotherapy treatment for their current cancer therapy.
- HIV-positive patients will not be excluded.
Where it is running
- Stanford University — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.